These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
463 related articles for article (PubMed ID: 28717051)
1. Detection of markers predictive of macrolide and fluoroquinolone resistance in Pitt R; Fifer H; Woodford N; Alexander S Sex Transm Infect; 2018 Feb; 94(1):9-13. PubMed ID: 28717051 [TBL] [Abstract][Full Text] [Related]
2. Macrolide and fluoroquinolone associated mutations in Mycoplasma genitalium in a retrospective study of male and female patients seeking care at a STI Clinic in Guangzhou, China, 2016-2018. Ke W; Li D; Tso LS; Wei R; Lan Y; Chen Z; Zhang X; Wang L; Liang C; Liao Y; Chen H; Liu Y; Zheng H; Yang L BMC Infect Dis; 2020 Dec; 20(1):950. PubMed ID: 33308173 [TBL] [Abstract][Full Text] [Related]
3. Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance. Couldwell DL; Tagg KA; Jeoffreys NJ; Gilbert GL Int J STD AIDS; 2013 Oct; 24(10):822-8. PubMed ID: 24052013 [TBL] [Abstract][Full Text] [Related]
4. Remarkable increase in fluoroquinolone-resistant Mycoplasma genitalium in Japan. Kikuchi M; Ito S; Yasuda M; Tsuchiya T; Hatazaki K; Takanashi M; Ezaki T; Deguchi T J Antimicrob Chemother; 2014 Sep; 69(9):2376-82. PubMed ID: 24894419 [TBL] [Abstract][Full Text] [Related]
5. Detection of markers predictive of macrolide and fluoroquinolone resistance in Day MJ; Cole MJ; Fifer H; Woodford N; Pitt R Sex Transm Infect; 2022 May; 98(3):215-218. PubMed ID: 34088790 [TBL] [Abstract][Full Text] [Related]
6. Surveillance of the prevalence of macrolide and/or fluoroquinolone resistance-associated mutations in Mycoplasma genitalium in Japan. Deguchi T; Ito S; Yasuda M; Sato Y; Uchida C; Sawamura M; Manda K; Takanashi M; Kiyota H J Infect Chemother; 2018 Nov; 24(11):861-867. PubMed ID: 30190106 [TBL] [Abstract][Full Text] [Related]
7. Macrolide and fluoroquinolone resistance-associated mutations in Mycoplasma genitalium in Johannesburg, South Africa, 2007-2014. Muller EE; Mahlangu MP; Lewis DA; Kularatne RS BMC Infect Dis; 2019 Feb; 19(1):148. PubMed ID: 30760230 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of Mycoplasma genitalium and mutations associated with macrolide and fluoroquinolone resistance in Finland. Hokynar K; Hiltunen-Back E; Mannonen L; Puolakkainen M Int J STD AIDS; 2018 Aug; 29(9):904-907. PubMed ID: 29631509 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of macrolide and fluoroquinolone resistance-mediating mutations in Mycoplasma genitalium in five cities in Russia and Estonia. Shipitsyna E; Rumyantseva T; Golparian D; Khayrullina G; Lagos AC; Edelstein I; Joers K; Jensen JS; Savicheva A; Rudneva N; Sukhanova L; Kozlov R; Guschin A; Unemo M PLoS One; 2017; 12(4):e0175763. PubMed ID: 28407014 [TBL] [Abstract][Full Text] [Related]
12. Emergence of Mycoplasma genitalium strains showing mutations associated with macrolide and fluoroquinolone resistance in the region Dresden, Germany. Dumke R; Thürmer A; Jacobs E Diagn Microbiol Infect Dis; 2016 Oct; 86(2):221-3. PubMed ID: 27448452 [TBL] [Abstract][Full Text] [Related]
13. High levels of macrolide resistance-associated mutations in Mycoplasma genitalium warrant antibiotic susceptibility-guided treatment. Nijhuis RH; Severs TT; Van der Vegt DS; Van Zwet AA; Kusters JG J Antimicrob Chemother; 2015 Sep; 70(9):2515-8. PubMed ID: 25995292 [TBL] [Abstract][Full Text] [Related]
14. Increasing Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium. Murray GL; Bradshaw CS; Bissessor M; Danielewski J; Garland SM; Jensen JS; Fairley CK; Tabrizi SN Emerg Infect Dis; 2017 May; 23(5):809-812. PubMed ID: 28418319 [TBL] [Abstract][Full Text] [Related]
15. Treatment efficacy, treatment failures and selection of macrolide resistance in patients with high load of Mycoplasma genitalium during treatment of male urethritis with josamycin. Guschin A; Ryzhikh P; Rumyantseva T; Gomberg M; Unemo M BMC Infect Dis; 2015 Feb; 15():40. PubMed ID: 25645440 [TBL] [Abstract][Full Text] [Related]
16. Mycoplasma genitalium in Singapore is associated with Chlamydia trachomatis infection and displays high macrolide and Fluoroquinolone resistance rates. Hart T; Tang WY; Mansoor SAB; Chio MTW; Barkham T BMC Infect Dis; 2020 Apr; 20(1):314. PubMed ID: 32345231 [TBL] [Abstract][Full Text] [Related]
17. High prevalence of antibiotic-resistant Mycoplasma genitalium in nongonococcal urethritis: the need for routine testing and the inadequacy of current treatment options. Pond MJ; Nori AV; Witney AA; Lopeman RC; Butcher PD; Sadiq ST Clin Infect Dis; 2014 Mar; 58(5):631-7. PubMed ID: 24280088 [TBL] [Abstract][Full Text] [Related]
18. Mycoplasma genitalium Macrolide and Fluoroquinolone Resistance: Prevalence and Risk Factors Among a 2013-2014 Cohort of Patients in Barcelona, Spain. Barberá MJ; Fernández-Huerta M; Jensen JS; Caballero E; Andreu A Sex Transm Dis; 2017 Aug; 44(8):457-462. PubMed ID: 28703723 [TBL] [Abstract][Full Text] [Related]
19. Guided antibiotic therapy for Mycoplasma genitalium infections: Analysis of mutations associated with resistance to macrolides and fluoroquinolones. Piñeiro L; Idigoras P; de la Caba I; López-Olaizola M; Cilla G Enferm Infecc Microbiol Clin (Engl Ed); 2019; 37(6):394-397. PubMed ID: 30396750 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of Wang L; Li Z; Wan C; Tian X; Liu H; Li Y Int J STD AIDS; 2023 Jul; 34(8):518-524. PubMed ID: 36929876 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]